SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-008663
Filing Date
2022-05-13
Accepted
2022-05-13 08:18:21
Documents
13
Period of Report
2022-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krbp-20220513x8k.htm   iXBRL 8-K 35103
2 EX-99.1 krbp-20220513xex99d1.htm EX-99.1 211789
  Complete submission text file 0001558370-22-008663.txt   385572

Data Files

Seq Description Document Type Size
3 EX-101.SCH krbp-20220513.xsd EX-101.SCH 3046
4 EX-101.LAB krbp-20220513_lab.xml EX-101.LAB 16584
5 EX-101.PRE krbp-20220513_pre.xml EX-101.PRE 10537
7 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20220513x8k_htm.xml XML 5029
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 22920336
SIC: 2836 Biological Products, (No Diagnostic Substances)